Table 5.
Baseline Serum Lipids, in Tertiles, Predicting Impairment on TMT-Ba
| Lipids in Tertiles
|
||||||||
|---|---|---|---|---|---|---|---|---|
| Total N
|
Categorical
|
2 vs. 1
|
3 vs. 1
|
|||||
| Lipid | Events | HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | |
| Total SM | 34 | 87 | 1.33 (0.86-2.06) | 0.196 | 1.25 (0.50-3.13) | 0.630 | 1.76 (0.73-4.21) | 0.205 |
| Ceramides | ||||||||
| C16:0 | 33 | 80 | 1.15 (0.76-1.73) | 0.514 | 2.18 (0.90-5.28) | 0.085 | 1.35 (0.56-3.28) | 0.507 |
| C18:0 | 26 | 65 | 0.84 (0.50-1.40) | 0.499 | 1.06 (0.38-2.94) | 0.908 | 0.68 (0.23-2.00) | 0.488 |
| C20:0 | 27 | 67 | 1.14 (0.71-1.83) | 0.576 | 1.86 (0.67-5.21) | 0.236 | 1.39 (0.51-3.80) | 0.525 |
| C22:0 | 32 | 82 | 1.17 (0.74-1.83) | 0.506 | 1.95 (0.77-4.92) | 0.156 | 1.43 (0.54-3.83) | 0.475 |
| C24:1 | 34 | 86 | 1.15 (0.76-1.74) | 0.502 | 2.29 (0.94-5.54) | 0.067 | 1.44 (0.58-3.59) | 0.437 |
| C24:0 | 34 | 86 | 1.25 (0.83-1.90) | 0.288 | 1.54 (0.60-3.95) | 0.372 | 1.61 (0.69-3.79) | 0.274 |
| Galactosyl C12:0 | 26 | 69 | 1.02 (0.63-1.65) | 0.936 | 1.07 (0.37-3.12) | 0.904 | 1.04 (0.40-2.74) | 0.931 |
| Lactosyl C12:0 | 29 | 67 | 1.28 (0.78-2.08) | 0.330 | 1.38 (0.55-3.51) | 0.494 | 1.62 (0.60-4.35) | 0.341 |
| Stearoyl | 33 | 84 | 1.13 (0.75-1.72) | 0.559 | 1.89 (0.78-4.59) | 0.159 | 1.33 (0.54-3.27) | 0.536 |
| Sulfatide | 29 | 73 | 1.51 (0.91-2.52) | 0.110 | 0.75 (0.27-2.04) | 0.568 | 2.20 (0.87-5.53) | 0.094 |
| SM/Cholesterol ratio | 34 | 86 | 1.34 (0.86-2.07) | 0.192 | 1.43 (0.58-3.49) | 0.434 | 1.80 (0.74-4.37) | 0.193 |
| Total cholesterol | 34 | 87 | 0.88 (0.58-1.34) | 0.564 | 1.49 (0.66-3.40) | 0.340 | 0.75 (0.30-1.89) | 0.540 |
HR = Hazard Ratio; CI = Confidence Interval
a
Models control for baseline age, blood glucose level, and BMI